Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53

J Virol. 2005 Jul;79(14):9296-300. doi: 10.1128/JVI.79.14.9296-9300.2005.

Abstract

The ubiquitin-protein ligase E6-AP is utilized by the E6 oncoprotein of human papillomaviruses (HPVs) associated with cervical cancer to target the tumor suppressor p53 for degradation. Here, we report that downregulation of E6-AP expression by RNA interference results in both the accumulation of p53 and growth suppression of the HPV-positive cervical cancer cell lines HeLa and SiHa. In addition, HeLa cells, in which p53 expression was suppressed by RNA interference, are significantly less sensitive to the downregulation of E6-AP expression with respect to growth suppression than parental HeLa cells. These data indicate that the anti-growth-suppressive properties of E6-AP in HPV-positive cells depend on its ability to induce p53 degradation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Down-Regulation
  • Female
  • HeLa Cells
  • Humans
  • Papillomaviridae / isolation & purification*
  • RNA Interference*
  • RNA, Small Interfering / therapeutic use
  • Tumor Suppressor Protein p53 / physiology*
  • Ubiquitin-Protein Ligases / antagonists & inhibitors*
  • Ubiquitin-Protein Ligases / genetics
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / therapy*
  • Uterine Cervical Neoplasms / virology*

Substances

  • RNA, Small Interfering
  • Tumor Suppressor Protein p53
  • UBE3A protein, human
  • Ubiquitin-Protein Ligases